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TagedH1Impact of Prior Coronary Artery Bypass Grafting in
Patients ≥75 Years Old Presenting With Acute
Myocardial Infarction (From the National Readmission
Database)TagedEn
,

TagedPAlejandro Lemor, MD, MSa *, Gabriel A. Hernandez, MDb, Mir B Basir, DOa, Sati Patel, MDa,
Pedro A. Villablanca, MD, MSa, Khaldoon Alaswad, MDa, and William O’Neill, MDaTagedEn
Patients ≥75 years old presenting with acute myocardial infarction (AMI) have complex
coronary anatomy in part due to prior coronary artery bypass grafting (CABG), percutaneous coronary interventions (PCI), calcific and valvular disease. Using the National
Readmission Database from January 2016 to November 2017, we identified hospital
admissions for acute myocardial infarction in patients ≥75 years old and divided them
based on a history of CABG. We evaluated in-hospital outcomes, 30-day mortality, 30-day
readmission and predictors of PCI in cohorts. Out of a total of 296,062 patients ≥75 years
old presenting with an AMI, 42,147 (14%) had history of previous CABG. Most presented
with a non-ST segment elevation myocardial infarction, and those with previous CABG
had higher burden of co-morbidities and were more commonly man. The in-hospital mortality was significantly lower in those with previous CABG (6.7% vs 8.8%, adjusted odds
ratio, 0.88, 95% confidence interval, 0.82 to 0.94). Medical therapy was more common in
those with previous CABG and 30-day readmission rates were seen more frequently in
those with prior CABG. Predictors of not undergoing PCI included previous PCI, female,
older ager groups, heart failure, dementia, malignancy, and higher number of co-morbidities. In conclusion, in patients ≥75 years old with AMI the presence of prior CABG was
associated with lower odds of in-hospital and 30-day mortality, as well as lower complications rates, and a decreased use of invasive strategies (PCI, CABG, and MCS). However,
30-day MACE readmission was higher in those with previous CABG. © 2020 Elsevier
Inc. All rights reserved. (Am J Cardiol 2020;135:9−16)

TagedH1BackgroundTagedEn
TagedPAcute cardiovascular disease is a leading cause of morbidity and mortality in adults of any age, however elderly
patients are at a higher risk for adverse outcomes, including
mortality and rehospitalizations.1 With improvement in
revascularization options for both stable and acute coronary
disease and resultant increase life expectancy, elderly
patients presenting with acute myocardial infarction (AMI)
have complex coronary anatomy in part due to previous
coronary artery bypass grafting (CABG), percutaneous coronary interventions (PCI), calcific and valvular disease.1,2
Moreover, aging is also associated with higher rates of noncardiac co-morbidities such as renal disease, cognitive dysfunction and polypharmacy which complicates treatment
strategies such as antiplatelet and anticoagulant therapies,
risk of contrast-induced nephropathy and timely discharge.
With this inherent age disparity and less invasive revascularization approach for AMI in elderly patients we sought
a
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to investigate whether preexisting CABG has any impact in
the treatment plan and in hospital outcomes.TagedEn
TagedH1MethodsTagedEn
TagedPThe study cohort was derived from the National Readmission Database (NRD), a publicly available database of
all-payer hospital inpatient stays developed by the Agency
for Healthcare Research and Quality as part of the Healthcare Cost and Utilization Project. The NRD was constructed
from 22 States with reliable and verified patient linkage
numbers in the State Inpatient Databases that could be used
to track the patient across hospitals within a State, while
adhering to strict privacy guidelines. We used the NRD
database from January 2016 to November 2017.TagedEn
TagedPThe NRD database includes approximately 14 million
patients and around 2,000 hospitals per year. National estimates are obtained using sampling weights provided.
Patients have a unique identifier, which allows each patient
to be tracked (the variable named “NRD_visitlink”). We
determined the time between the first admission and the
readmission by using the variable “NRD_daystoevent” and
calculating the difference between that variable and the
length of stay. A detailed explanation of all the variables in
the NRD is available online (https://www.hcup-us.ahrq.
gov/nrdoverview.jsp). Institutional Review Board (IRB)
review and approval was not required as the NRD is a
www.ajconline.org
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publicly available database containing de-identified patient
information.TagedEn
TagedPThe study population was identified using the International Classification of Diseases, Tenth Edition, Clinical
Modification (ICD-10-CM) diagnostic codes for a primary
discharge diagnosis of acute myocardial infarction (ICD10-CM code I21.x) and those ≥75 years old. Patients were
then divided into 2 cohorts based on a previous history of
CABG using the ICD-10-CM diagnostic code of Z95.1
(Presence of aortocoronary bypass graft). The exclusion criteria consisted of patients admitted during the month of
December, as NRD patient tracking is limited to a single
calendar year, (n = 33,093), younger than 75 years old
(n = 810,154), same day admission-transfers (n = 22,943),
out of state patients (n = 21,264), and patients who did not
have mortality data (n = 94) (Figure 1). Baseline characteristics, such as age, gender, and relevant comorbidities were
collected. The severity of co-morbid conditions was defined
using a validated Deyo modification of Charlson Co-morbidity Index.3,4 Other characteristics such as teaching status
of the hospital, median household income, insurance status,
and discharge disposition were also included.TagedEn
TagedPThe primary outcome was in-hospital mortality. Secondary outcomes included 30-day mortality, 30-day readmission rate, 30-day major adverse cardiovascular events
(MACE) readmissions, acute kidney injury (AKI), AKI
requiring dialysis, acute ischemic stroke, acute respiratory
failure, acute liver failure, palliative care consultation,

TagedEn

TagedFiur

length of stay, and hospital costs. Thirty-day MACE readmissions included all patients with a primary readmission
diagnosis of acute coronary syndrome, acute heart failure,
and ventricular tachycardia/fibrillation. Principal etiologies
of readmission were also evaluated for both cohorts.TagedEn
TagedPUnivariate differences in baseline characteristics
between both cohorts were evaluated using Pearson chisquare tests for categorical variables and Wilcoxon ranksum tests for continuous variables. Multivariate linear and
logistic regression were used to compare hospital outcomes
between groups, adjusting for potential confounders, such
as age, gender, type of acute coronary syndrome, hypertension, diabetes, dyslipidemia, heart failure, previous myocardial infarction (MI), previous PCI, smoker, end stage renal
disease (ESRD), chronic obstructive pulmonary disease
(COPD), dementia, peripheral artery disease (PAD), malignancy, obesity, atrial fibrillation, Do not resuscitate (DNR)
status, Charlson comorbidity index, teaching status, hospital
bed size, and median household income. Statistical analysis
was performed with STATA version 14 (StataCorp, Texas).
A p-value less than 0.05 was considered significant for all
the analyses.TagedEn
TagedH1ResultsTagedEn
TagedPA total of 296,062 patients ≥75 years old presented with
an acute myocardial infarction, out of which 14%
(N = 42,147) had history of previous CABG. The majority

Figure 1. Flowchart with patient selection. A total of 1,837,611 patients with acute coronary syndrome were identified from 2016 to 2017; among which
373,456 were ≥75 years. After exclusion criteria, 296,062 patients were included in the analysis; 42,147 (14.2%) had a prior CABG and 253,915 didn’t have
a prior CABG. CABG = coronary artery bypass grafting. TagedEn
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TagedEnTable 1
Baseline characteristics
Prior CABG
Variable
Type of myocardial infarction
NSTEMI
STEMI
Anterior wall
Inferior wall
Other
Age (median [IQR])
Men
Hypertension
Diabetes Mellitus
Heart failure
Systolic heart failure
Dyslipidemia
Prior percutaneous coronary intervention
Obesity
Smoker
Chronic obstructive pulmonary disease
End Stage Renal Disease
Peripheral artery disease
Atrial fibrillation
Prior implantable cardioverter defibrillator
Do Not Resuscitate (DNR) Status
Dementia
Malignancy
Charlson Comorbidity Index 33
Other characteristics
Teaching hospital
Hospital Bed Size
Small
Medium
Large
Median household income percentile
0 - 25th
26th - 50th
51st - 75th
76th - 100th
Primary Payer
Medicare
Medicaid
Private Insurance
Self-pay/ Other
Discharge disposition
Home
Nursing Home/ Facility
Other

Overall (N = 296,062)

YES (N = 42,147)

NO (N = 253,915)

p Value

79.3%
20.7%
32.5%
42.9%
24.6%
83 (78-88)
49.8%
86.3%
37.6%
45.1%
25.5%
65.8%
16.8%
9.4%
1.0%
22.8%
3.1%
15.6%
31.9%
2.3%
20.2%
16.4%
5.3%
65.8%

89.2%
10.8%
17.4%
45.9%
36.8%
82 (78-87)
69.0%
91.3%
48.7%
52.9%
31.1%
77.8%
28.2%
9.8%
0.8%
22.6%
4.0%
21.4%
34.7%
6.0%
18.6%
13.8%
5.0%
76.1%

77.7%
22.3%
33.7%
42.7%
23.6%
83 (78-88)
46.5%
85.4%
35.8%
43.8%
24.6%
63.8%
14.9%
9.3%
1.0%
22.9%
3.0%
14.7%
31.5%
1.6%
20.5%
16.8%
5.3%
64.1%

<0.001

62.8%

62.5%

62.9%

0.513

15.5%
29.9%
54.6%

15.7%
30.1%
54.3%

15.5%
29.9%
54.7%

0.686

27.5%
28.7%
25.0%
18.8%

26.9%
29.6%
25.0%
18.5%

27.5%
28.6%
25.0%
18.9%

0.037

94.3%
0.9%
3.2%
1.6%

94.6%
0.6%
3.1%
1.8%

94.3%
1.0%
3.3%
1.5%

<0.001

71.9%
24.6%
3.5%

76.8%
19.7%
3.5%

71.0%
25.5%
3.5%

<0.001

presented with non-ST segment elevation myocardial
infarction (NSTEMI) (79%), with an even higher frequency
in those with previous CABG (89.2% vs 77.7%, p
<0.001). In patients presenting with ST segment elevation
myocardial infarction (STEMI) (21%), inferior wall
STEMI was most commonly seen (42.9%), followed by
anterior wall MI (32.5%), and 24.6% were located on
another wall or unspecified location of MI. The median
age for those with previous CABG was 82 years and
those without previous CABG had a median age of
83 years old. Patients with previous CABG were more
likely to be male compared wih those without it (69% vs

<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
0.017
0.004
0.427
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
0.044
<0.001

46.5%, p <0.001) and those with CABG had a higher burden of comorbidities (Table 1).TagedEn
TagedPMost patients underwent medical management irrespective of the history of CABG (69.2% in those with previous
CABG and 58.1% in those without previous CABG). As
expected, those with previous CABG had lower rates redo
CABG (0.9% vs 5.6%, p <0.001) and interestingly, lower
rates of PCI (30% vs 36.7%, p <0.0001). When patients
were evaluated by type of AMI, those with CABG presenting with STEMI had lower rates of PCI (52.2% vs 65.7%, p
<0.001). Among patients presenting with NSTEMI, the
overall revascularization rate was 33.5%, with lower rates

Downloaded for Anonymous User (n/a) at Henry Ford Hospital / Henry Ford Health System (CS North America) from ClinicalKey.com by Elsevier on December 15, 2020.
For personal use only. No other uses without permission. Copyright ©2020. Elsevier Inc. All rights reserved.

TagedEn12

The American Journal of Cardiology (www.ajconline.org)

TagedEnTable 2
Procedural outcomes
Prior CABG
All AMI

Overall (N = 296,062)

YES (N = 42,147)

NO (N = 253,915)

p Value

Coronary Angiogram
Percutaneous coronary intervention
Single-vessel PCI
Multivessel PCI
Coronary artery bypass grafting
Medical treatment
Intra-aortic balloon pump
Impella
STEMI
Coronary Angiogram
Percutaneous coronary intervention
Single-vessel PCI
Multivessel PCI
Coronary artery bypass grafting
Medical treatment
Intra-aortic balloon pump
Impella
NSTEMI
Coronary angiogram
Percutaneous coronary intervention
Single-vessel PCI
Multivessel PCI
Coronary artery bypass grafting
Medical treatment
Intra-aortic balloon pump
Impella

55.9%
35.8%
27.7%
8.1%
4.9%
59.7%
2.8%
0.8%
Overall (N = 61,185)
74.2%
64.7%
52.5%
12.2%
3.7%
32.6%
7.1%
1.4%
Overall (N = 234,877)
51.1%
28.2%
21.2%
7.1%
5.2%
66.7%
1.7%
0.6%

51.5%
30.0%
23.3%
6.7%
0.9%
69.2%
1.2%
0.4%
YES (N = 4,560)
66.2%
52.2%
40.4%
11.7%
0.9%
47.3%
4.5%
0.6%
YES (N = 37,587)
49.7%
27.4%
21.2%
6.1%
0.9%
71.9%
0.8%
0.4%

56.6%
36.7%
28.4%
8.4%
5.6%
58.1%
3.1%
0.8%
NO (N = 56,625)
74.9%
65.7%
53.5%
12.3%
3.9%
31.4%
7.3%
1.5%
NO (N = 197,290)
51.4%
28.4%
21.2%
7.3%
6.0%
65.7%
1.8%
0.6%

<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
p Value
<0.001
<0.001
<0.001
0.561
<0.001
<0.001
<0.001
<0.001
p Value
0.002
0.008
0.882
<0.001
<0.001
<0.001
<0.001
<0.001

of PCI and CABG in the cohort of patients with previous
CABG. Patients with previous CABG had less likelihood of
undergoing multivessel PCI. The use of mechanical circulatory support, such as Intra-aortic balloon pump (IABP) and
Impella, was lower in those with previous CABG, regardless of the type of AMI (Table 2)TagedEn
TagedPThe primary outcome, in-hospital mortality, was significantly lower in those with previous CABG (6.7% vs 8.8%,
adjusted odds ratio [aOR]: 0.88, 95% confidence interval
[CI] 0.82 to 0.94). When analyzed by type of AMI, those
presenting with STEMI and previous CABG had no significant difference in mortality when compared to those without CABG (16.3% vs 16.7%, aOR 0.99 95% CI 0.86 to
1.13); however, those with NSTEMI and previous CABG
had significant lower odds of in-hospital mortality (5.5% vs
6.4%, aOR 0.83, 95% CI 0.76 to 0.90). A subgroup analysis
by age groups (75 to 80 years, 81 to 85 years, and >85
years) demonstrated that those patients in older age groups
with previous CABG had significantly lower mortality than
those without previous CABG (Figure 2).TagedEn
TagedPWhen comparing secondary outcomes between
cohorts, we found those with previous CABG had a
lower rate of 30-day mortality, cardiogenic shock, AKI,
acute ischemic stroke, blood transfusions, acute respiratory failure, and acute liver failure. The 30-day MACE
readmission and 30-day all-cause readmission was
higher in those with previous CABG (Figure 3). Hospital costs were significantly higher in those without previous CABG (Figure 4). Factors that associated either

with increased or lower odds for PCI during index
admission for AMI are shown in Figure 5.TagedEn
TagedH1DiscussionTagedEn
TagedPUsing real-world data, we evaluated a large cohort of
patients ≥ 75 years old who presented with AMI and provided new insights about the relationship of previous
CABG and in-hospital outcomes (Figure 6). The key findings of our study are (1) despite lower rates revascularization, patients with previous CABG had significantly lower
in-hospital mortality. (2) Subgroup analysis demonstrated
lower mortality rates in those older than 80 years old. (3)
Those with previous CABG had lower rates of in-hospital
complication, such as cardiogenic shock, AKI, respiratory
failure, liver failure, acute ischemic stroke, and blood transfusions. (4) Rates of revascularization (PCI or CABG) and
use of MCS were lower in those with previous CABG. (5)
30-day readmission rates for MACE were higher in those
patients with previous CABG, nonetheless, the 30-day mortality was still lower in those with previous CABG.TagedEn
TagedPEven though rates of CABG in the United States have
decreased,5 the prevalence of patients who have had CABG
will remain the same or will increase as the morbidity and
mortality in this patient population improves. Elderly
patients with previous CABG presenting with AMI can represent a challenge for physicians, as they can present with
atypical symptoms, ECGs may be less diagnostic than in
younger patients, and reperfusion therapies are less
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Figure 2. In-hospital mortality. The in-hospital mortality was significantly lower in those with prior CABG. Subgroup analysis showed no significant difference in mortality in STEMI; however, those with NSTEMI and prior CABG had significant lower mortality. Patients in older age groups with prior CABG
had significantly lower mortality than those without prior CABG.TagedEn

TagedEn

TagedFiur

TagedEn

Figure 3. Secondary outcomes. Patients with prior CABG had lower rates of 30-day mortality, however, had higher 30-day readmission and 30-day MACE
readmission rates. Lower complications rates were seen in those with prior CABG.TagedEn

TagedFiur

Figure 4. Total hospital costs for patients with and without prior CABG. The total hospital costs were significantly lower for patients with prior CABG.TagedEn
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Figure 5. Predictors of PCI during index admission for AMI. In patients ≥75 years old presenting with acute myocardial infarction, a history of prior CABG,
older age groups, female gender, NSTEMI, heart failure, COPD, dementia, malignancy, DNR status, atrial fibrillation, a Charlson Comorbidity Index >3
were independent predictors of medical management. Predictors of PCI included dyslipidemia, prior MI, peripheral arterial disease, prior PCI, obesity, teaching hospital, medium to large hospital size and a higher median household. AMI = acute myocardial infacrtion; CABG = coronary artery bypass grafting;
TagedEnPCITagedFiur = percutaneous coronary intervention.TagedEn

Figure 6. Summary of the study findings. Among patients 75 years and older who presented with an acute myocardial infarction, those with a history of prior
CABG had lower in-hospital and 30-day mortality, as well as lower rates of organ failure, rates of PCI, CABG, MCS use, length of stay and hospital costs
when compared with those without prior CABG.TagedEn
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frequently used.6,7 We found lower incidence of STEMI in
those with previous CABG and lower rates of PCI and redo CABG (less than 1%). As described by Fosbol et al, the
rates of repeated CABG in older individuals is low and
there is a significant variation between centers. Overall,
there has been a declining rate of re-do CABG over the
years with a steady increase in the rates of PCI.8 A subgroup analysis in our cohort evaluating mortality in those
who underwent CABG during the index admission,
revealed higher mortality in patients undergoing redo
CABG, although this was not statistically significant
(11.6% vs 6.2%, p = 0.06). A study by Welsh et al revealed
that patients with previous CABG presenting with STEMI
were less likely to undergo revascularization and had a
higher 90-day mortality.9 We reported similar findings
regarding a higher burden of comorbidities and lower revascularization rates in those with previous CABG, however,
we found lower in-hospital and 30-day mortality in those
with previous CABG. Even though in our study the
patients’ age was higher, the 30-day mortality was overall
lower in our cohort with AMI (6.7% for those with previous
CABG and 8.8% in those without previous CABG). The
lower mortality seen in our study highlights the protective
mechanism of CABG; because the grafts bypass the first 7cm segment of the coronary artery, which is the most common segment for new plaque rupture.10 This protective
mechanism of CABG has been described in previous
important trials, such as SYNTAX Trial and BARI Study,
in which the rates of repeated revascularization and/or MI
were higher in patients that underwent PCI at 5 to 10
years.11,12TagedEn
TagedPThe elderly population is typically underrepresented in
randomized control trials; however, the TACTICS-TIMI 18
trial found a reduction of death or MI at 6 months in
patients >75 years old undergoing an invasive versus conservative strategy, though, the rates of bleeding were higher
for those undergoing an invasive strategy.13 In our study,
almost 70% of patients with previous CABG underwent a
conservative treatment and around 60% of those without
previous CABG also underwent a conservative approach.
Lower rates of revascularization in those with previous
CABG could potentially explain the increased odds of 30day MACE readmission as well as the higher number of
comorbidities. Nonetheless, in those patients with previous
CABG, 8.7% underwent PCI during the readmission compared to 10.9% in those without previous CABG
(p = 0.008). Emphasizing the importance of guidelinedirected medical therapy in the elderly, which is less frequently accomplished when compared with younger
patients.14 Optimal medical therapy benefits preventing
MACE and symptoms in this morbid population,15 in addition to choosing early invasive strategy when appropriate,
regardless of the age group.16,17 This approach is supported
by the ACC/AHA NSTEMI guidelines which recommend
guideline-directed medical therapy, early invasive strategy
and revascularization as appropriate for patients ≥75 years
old.18TagedEn
TagedPLastly, we reported predictors favoring PCI versus medical management in our cohort; factors associated with lower
rates of PCI included previous CABG, older age groups (81
to 85 years and >85 years), female gender, NSTEMI, higher
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number of comorbidities, malignancy, DNR status, and
dementia among others. In contrast, predictors of undergoing PCI included previous MI, previous PCI, obesity, PAD,
teaching hospital and larger hospital bed size. Hao et al19
described similar factors associated with not performing
PCI in AMI, including female gender, older age groups,
acute heart failure, and NSTEMI. There are several limitations to the present study. We are not able to identify the
timing of the previous CABG, and neither to differentiate if
the culprit lesion was a native vessel or a graft. Mortality
data does not distinguish between cardiac and non-cardiac
causes of death. In addition, the study is limited to in-hospital and 30-day outcomes only and long-term outcome data
are not available. The NRD data is based on ICD-10-CM
codes, and like any administrative database, there is a possibility of coding error. Lack of information about laboratory
results, medications, and imaging findings renders a more
comprehensive analysis unfeasible with this database.
Despite these limitations, our results demonstrate robust
findings using real world data of the impact of previous
CABG in the outcomes of patients ≥75 years old presenting
with AMI.TagedEn
TagedPIn conclusion, patients ≥75 years old presenting with
AMI are more frequently treated conservatively than by
revascularization. The presence of previous CABG was
associated with lower odds of in-hospital and 30-day mortality, as well as lower complication rates. Thirty-day
MACE readmission rates were higher in those with previous CABG, possibly secondary to a combination of higher
co-morbidities and a more frequent use of conservative
management during the index hospitalization. Predictors
for a conservative strategy included previous CABG,
female gender, older ager groups, heart failure, dementia,
malignancy, and higher number of comorbidities.TagedEn
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